版本:
中国

BRIEF-Takeda says presentation of real-world analyses supporting effectiveness of Entyvio

May 8 Takeda Pharmaceutical Co Ltd

* Announced presentation of eight real-world analyses supporting effectiveness and safety of entyvio

* Analyses of Entyvio for treatment of adults with moderately to severely active ulcerative colitis and crohn's disease Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐